1. State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Ren Ji Hospital, School of Medicine and School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China 2. Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China
✉ Corresponding author: Weiliang Xia, PhD, School of Biomedical Engineering and Med-X Research Institute, Shanghai Jiao Tong University, 1954 Huashan Road, Shanghai, 200030, China. Phone: +86-21-62933351; Mobil: +86-13585887951. E-mail: wlxiaedu.cnMore
Citation:
Li F, Li X, Li Z, Ji W, Lu S, Xia W. βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum. Theranostics 2023; 13(13):4391. doi:10.7150/thno.86780. https://www.thno.org/v13p4391.htm
Li, F., Li, X., Li, Z., Ji, W., Lu, S., Xia, W. (2023). βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum. Theranostics, 13(13), 4391. https://doi.org/10.7150/thno.86780.
ACS
Li, F.; Li, X.; Li, Z.; Ji, W.; Lu, S.; Xia, W. βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum. Theranostics 2023, 13 (13), 4391. DOI: 10.7150/thno.86780.
NLM
Li F, Li X, Li Z, Ji W, Lu S, Xia W. βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum. Theranostics 2023; 13(13):4391. doi:10.7150/thno.86780. https://www.thno.org/v13p4391.htm
CSE
Li F, Li X, Li Z, Ji W, Lu S, Xia W. 2023. βKlotho is identified as a target for theranostics in non-small cell lung cancer: Erratum. Theranostics. 13(13):4391.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.